Cosmeceuticals

3,756 views

Published on

0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
3,756
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
83
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Cosmeceuticals

  1. 1. INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS 767 Beta Drive Cleveland, OH • 44143-2326 • USA Toll Free US Tel: 800.927.5900 or +1 440.684.9600 Fax: +1 440.646.0484 E-mail: info@freedoniagroup.com The Freedonia Group www.freedoniagroup.com Table of Contents 2 List of Tables & Charts 3 Study Overview 4 Sample Text, Table & Chart 5 Sample Profile, Table & Forecast 6 Order Form 7 About Freedonia, Custom Research, Related Studies, Corporate Use License 8 CLICK TO VIEW US Industry Study with Forecasts to 2010 & 2015 Study #2114 | October 2006 | $4400 | 305 pages Cosmeceuticals
  2. 2. Study #2114 October 2006 $4400 305 Pages Cosmeceuticals US Industry Study with Forecasts to 2010 & 2015 Page Order now, click here! Click here to purchase online Table of Contents EXECUTIVE SUMMARY MARKET ENVIRONMENT General.........................................4 Macroeconomic Overview..................5 Demographic Trends........................8 Consumer Spending.........................9 Dermatological Conditions..............11 Hair Loss..................................12 Skin Conditions..........................14 Cosmetic Toiletry Market.............15 Skin Care Products......................17 Hair Care Products......................21 Oral Hygiene Products.................23 Other Cosmetics Toiletries.........25 Cosmetic Surgery Procedures...........27 Dermatological Pharmaceutical Shipments.................................30 Nanotechnology in Cosmeceuticals..32 Regulatory Considerations..............34 Historical Market Trends.................36 International Markets....................38 COSMECEUTICAL PRODUCTS General.......................................41 Skin Care Cosmeceuticals................44 Age-Defying Products..................46 Types.....................................50 Applications...........................54 Acne Preparations.......................56 Medicated Lotions......................59 Sun Protection Products..............61 Other Skin Care Products.............63 Hair Care Cosmeceuticals................65 Hair Growth Products..................66 Finasteride-Based....................67 Minoxidil-Based Other...........68 Anti-Dandruff Shampoos..............70 Professional Cosmeceutical Products 72 Botulinum Toxin-Based...............74 Tissue Fillers.............................77 Hyaluronic Acid.......................78 Other Tissue Fillers..................80 Collagen..............................81 Calcium Hydroxylapatite.........83 Synthetic Polymers................83 Other Professional Products..........85 Other Cosmeceutical Products.........88 Lip Care Products.......................90 Tooth Whiteners.........................92 Professional Tooth Whitening ...94 Over-The-Counter Tooth Whitening ...........................95 Oral Beauty Supplements.............96 All Other Cosmeceutical Products..98 Hair Growth Retardants.............98 Anti-Cellulite/Body Slimming....99 Color Cosmetics..................... 100 Breast/Penis Enhancers.......... 100 Nail, Hand Foot.................. 101 COSMECEUTICAL CHEMICALS General..................................... 102 Antioxidants.............................. 105 Vitamin A Compounds............... 107 Vitamin E Compounds............... 110 Vitamin C Compounds............... 111 Coenzyme Q10 Other.............. 113 Sunscreens................................. 115 Organic................................... 118 Inorganic................................ 118 Acids........................................ 120 Alpha Hydroxy Acids................. 121 Other Acids............................. 123 Enzymes.................................... 125 Botulinum Toxin....................... 127 Other Enzymes......................... 129 Proteins.................................... 131 Collagen................................. 132 Amino Acids............................ 133 Elastin.................................... 136 Other Proteins......................... 136 Botanicals................................. 138 Other........................................ 142 Finasteride.............................. 143 Hyaluronic Acid........................ 144 All Other................................. 146 INDUSTRY STRUCTURE General..................................... 149 Market Share.............................. 153 Cosmeceutical Products............. 154 Procter Gamble................... 156 Johnson Johnson............... 157 L’Oreal.................................. 158 Estee Lauder......................... 158 Avon Products....................... 159 Allergan............................... 159 Other Market Leaders.............. 160 Cosmeceutical Chemicals........... 162 Royal DSM............................ 164 BASF.................................... 164 Cognis................................. 165 Merck................................... 165 Allergan............................... 166 Eastman............................... 166 Croda................................... 166 Other Market Leaders.............. 167 Marketing Distribution.............. 168 Manufacturing............................ 170 Competitive Strategies................. 171 Research Development.............. 173 Cooperative Agreements............... 175 Acquisitions Divestitures........... 180 Company Profiles Active Organics........................... 184 Allergan Incorporated.................. 186 Arch Chemicals........................... 191 Ashland Incorporated.................. 194 Avon Products............................ 195 BASF AG.................................... 199 Bayer AG................................... 202 Beiersdorf AG............................. 203 Bristol-Myers Squibb.................... 206 Ciba Specialty Chemicals.............. 208 Clariant International.................. 210 Cognis Deutschland..................... 211 Colgate-Palmolive....................... 215 Croda International..................... 217 Degussa AG................................ 222 (continued on next page)
  3. 3. Study #2114 October 2006 $4400 305 Pages Cosmeceuticals US Industry Study with Forecasts to 2010 2015 Page Order now, click here! Click here to purchase online (continued from previous page) Desert Whale Jojoba.................... 225 DuPont (EI) de Nemours............... 226 Eastman Chemical....................... 227 Estee Lauder.............................. 229 Imperial Chemical Industries......... 235 Indena SpA................................ 236 International Specialty Products.... 238 Johnson Johnson..................... 240 Kao Corporation.......................... 245 Kyowa Hakko Kogyo.................... 248 L’Oreal SA.................................. 250 Medicis Pharmaceutical ..................258 Merck Company...........................262 Murad Incorporated........................263 Novartis AG...................................265 NV Perricone MD............................267 Obagi Medical Products...................269 Pfizer Incorporated........................271 Procter Gamble...........................273 Rhodia SA.....................................277 Roche Holding...............................279 Royal DSM NV................................280 Schering-Plough Corporation............282 SkinMedica Incorporated.................284 Symrise GmbH Company KG..........287 Unilever Group........................... 289 Other Companies Mentioned in Study.................................. 292 EXECUTIVE SUMMARY 1 Summary Table..........................3 MARKET ENVIRONMENT 1 Macroeconomic Indicators...........7 2 Demographic Trends...................9 3 Personal Consumption Expenditures Disposable Personal Income...................11 4 Selected Dermatological Conditions...........................12 5 Cosmetic Toiletry Supply Demand..................17 6 Skin Care Product Supply Demand..................21 7 Hair Care Product Supply Demand..................23 8 Oral Hygiene Product Supply Demand..................25 9 Other Cosmetic Toiletry Product Supply Demand......27 10 Cosmetic Surgery Procedures......29 11 Dermatological Pharmaceutical Shipments...........................32 12 Cosmeceutical Chemical Market, 1995-2005................38 COSMECEUTICAL PRODUCTS 1 Cosmeceutical Product Demand..43 Cht Cosmeceutical Product Demand by Type, 2005...........44 2 Skin Care Cosmeceutical Product Demand....................45 Cht Skin Care Cosmeceutical Product Demand by Type, 2005...........46 3 Age-Defying Cosmeceutical Product Demand....................50 4 Acne Preparation Cosmeceutical Product Demand....................59 5 Medicated Lotion Cosmeceutical Product Demand....................60 6 Sun Protection Cosmeceutical Product Demand....................63 7 Other Skin Care Cosmeceutical Product Demand....................65 8 Hair Care Cosmeceutical Product Demand....................66 9 Hair Growth Cosmeceutical Product Demand....................67 10 Anti-Dandruff Cosmeceutical Product Demand....................72 11 Professional Cosmeceutical Product Demand....................74 12 Botulinum Toxin Cosmeceutical Product Demand....................76 13 Tissue Filler Cosmeceutical Product Demand....................78 14 Other Professional Cosmeceutical Product Demand....................88 15 Other Cosmeceutical Product Demand....................90 COSMECEUTICAL CHEMICALS 1 Cosmeceutical Chemical Demand............................. 104 Cht Cosmeceutical Chemical Demand by Type, 2005......... 104 2 Antioxidants: Cosmeceutical Applications....................... 107 3 Sunscreens: Cosmeceutical Applications....................... 117 4 Acids: Cosmeceutical Applications....................... 120 5 Enzymes: Cosmeceutical Applications....................... 127 6 Proteins: Cosmeceutical Applications....................... 132 7 Botanicals: Cosmeceutical Applications....................... 142 8 Other Cosmeceutical Chemical Demand................ 143 INDUSTRY STRUCTURE 1 US Cosmeceutical Product Chemical Sales by Company, 2005............... 151 Cht US Cosmeceutical Product Market Share by Company, 2005............... 156 Cht US Cosmeceutical Chemical Market Share by Company, 2005............... 164 2 RD Spending Patterns: Selected Cosmeceutical Suppliers....... 175 3 Selected Cooperative Agreements........................ 177 4 Selected Acquisitions Divestitures.................... 182 Company Profiles List of Tables/Charts
  4. 4. Study #2114 October 2006 $4400 305 Pages Cosmeceuticals US Industry Study with Forecasts to 2010 2015 Page Order now, click here! Copyright 2006 The Freedonia Group, Inc. Click here to purchase online US demand to grow 8.5% annually through 2010 Demand for cosmeceutical products is expected to increase 8.5 percent per year to over $8 billion in 2010, propelled by a stream of new and technologically advanced product introductions offering age-defying and other appearance-en- hancing benefits for an aging population. The rapid growth of the cosmeceutical market will continue to be based on a combination of science and astute mar- keting, with evidence regarding product claims often far from conclusive. Professional products to grow the fastest Skin care products will account for 60 percent of all cosmeceutical product demand in 2010. Anti-aging products will achieve above-average growth, with gains driven by a highly receptive, fast- expanding group of middle-aged and relatively affluent consumers who want to prevent or redress visible damage to the skin caused by aging, ultraviolet radiation and other stressors. Improved formulations will further promote the use of age-defying products. Professional products are expected to experience the fastest growth among cosmeceutical products, achieving double-digit annual gains through 2010. Strong prospects for these products are the result of growing demand and ac- ceptance on the consumer side and the increasing availability and proficiency of practitioners. The aging of the US popu- lation, an increasingly competitive work force, continued exposure to beauty “ideals” in entertainment and advertising, and favorable consumer incomes are expected to spur continued interest in professional products. Botulinum toxin, hyaluronic acid to pace chemicals segment Demand for cosmeceutical chemicals will grow as producers increasingly develop more effective, value-added active ingredients to add to their product formulations. Chemicals used in profes- sional products will drive gains, with strong advances expected for botulinum toxin, the key ingredient in BOTOX; and hyaluronic acid, the substance on which three recently introduced dermal fillers, CAPTIQUE, HYLAFORM and RESTYLANE, are based. In addition to dermal fillers, hyaluronic acid is finding greater use in over-the-counter age- defying products, particularly skin care items. Other chemicals expected to record rapid gains include amino acids and antioxidants (e.g., vitamins A and C) which are the active ingredients in many anti-aging creams and lotions; botanical extracts, which serve a variety of cos- meceutical functions; and beta hydroxy acids, which have become an important ingredient in various skin care products due to their ability to offer safer exfoliant and cell renewal properties. The aging of the US population, continued exposure to beauty “ideals” in entertainment and advertis- ing, and favorable consumer incomes will help spur continued interest in professional cosmeceuticals. US Cosmeceutical Product Demand ($5.4 billion, 2005) Skin Care 62% Professional 10% Hair Care 13% Other Types 15%
  5. 5. Study #2114 October 2006 $4400 305 Pages Cosmeceuticals US Industry Study with Forecasts to 2010 2015 Page Order now, click here! Click here to purchase online CHART V-2 US COSMECEUTICAL CHEMICAL MARKET SHARE BY COMPANY, 2005 ($790 million) Market Leaders 44% Others 56% Croda Eastman Allergan BASF Cognis Merck Royal DSM 4% 5% 6% 6% 6% 6% 11% cosmeceutical products Tissue Fillers Demand for tissue fillers is expected to rise 13 percent per annum and reach $302 million in 2010, driven primarily by FDA approval of new products and the continued market penetration of hyaluronic acid. Approvals will result in more aggressive advertising as companies compete for a growing number of first time clients. Newly approved tissue fillers are expected to require no allergy pre-screening and can be administered in less than one hour, providing immediate and longer last- ing results than currently approved tissue fillers. Tissue fillers are composed of bovine collagen, processed human collagen, compositions of synthetic polymers or microspheres suspended in collagen solutions, hyaluronic acid, silicone oil, and calcium hydrox- ylapatite. Tissue fillers are commonly used to plump up facial lines, de- pressions and wrinkles, and are generally applied to the lower two-thirds of the face. Tissue fillers are also commonly used in lip augmentation procedures, providing fuller and plumper lips. Among the tissue fillers, hyaluronic acid is projected to achieve the most rapid gains through 2010. Gains will benefit as more individuals realize the performance advantages hyaluronic acid has over other inject- able materials. In addition, market penetration of hyaluronic acid will expand as many new products are poised to gain FDA approval over the next several years. Historically, collagen products dominated the tissue filler market. Collagen’s market position dramatically changed when hyaluronic acid was approved in December 2003, and in 2005, collagen accounted for only 20 percent of the total tissue filler market. Further competition will arise as other synthetic materials are likely to achieve FDA approval over the forecast period. 77 TABLE III-3 AGE-DEFYING COSMECEUTICAL PRODUCT DEMAND (million dollars) Item 1995 2000 2005 2010 2015 Population 35 + years (million) 129.3 142.7 153.5 162.8 171.8 $ age-defying/capita 1.8 5.7 9.8 15.4 23.4 Age-Defying Cosmeceutical Product 230 810 1500 2500 4020 By Type: Lotions 195 745 1400 2365 3820 Exfoliants, Masks Cleansers 35 65 100 135 200 By Application: Anti-Aging Facial 195 690 1275 2110 3370 Fade/Bleach 30 90 170 290 470 Anti-Aging Body 5 30 55 100 180 % age-defying 18.6 36.2 45.1 51.6 57.3 Skin Care Cosmeceutical Prdt Dmd 1235 2240 3325 4845 7010 Sample Text, Table Chart sample table sample text sample chart Copyright 2006 The Freedonia Group, Inc.
  6. 6. Study #2114 October 2006 $4400 305 Pages Cosmeceuticals US Industry Study with Forecasts to 2010 2015 Page Order now, click here! Click here to purchase online Medicis Pharmaceutical Corporation 8125 North Hayden Road Scottsdale, AZ 85258 602-808-8800 http://www.medicis.com Revenues: $360 million (2005) Employment: 355 (2005) Key Products: prescription treatments for skin disorders, and hyal- uronic acid-based dermal fillers Medicis is a specialty pharmaceutical company focused on the development and marketing of drugs for the treatment of dermatologic, pediatric and podiatric conditions. In addition, the Company has opera- tions in the marketing of dermal aesthetic products. As of December 2005, Medicis changed its fiscal year end from June to December. The Company participates in the cosmeceutical industry through the marketing of several prescription treatments for skin disorders, in addition to hyaluronic acid-based dermal fillers. Among Medicis’ treat- ments for skin disorders are products formulated to treat acne, rosacea, seborrheic dermatitis, hyperpigmentation and psoriasis. The Company sells hyaluronic acid-based dermal fillers primarily through a licensing agreement with Q-Med AB (Sweden), a biotechnology and medical device company that produces implants. Acne-Related Dermatological Products -- Of Medicis’ FY 2005 revenues of $377 million, acne-related dermatological products accounted for 30 percent, or approximately $113 million. Among the Company’s acne treatments are such products as DYNACIN, PLEX 258 COMPANY PROFILES TABLE IV-1 COSMECEUTICAL CHEMICAL DEMAND (million dollars) Item 1995 2000 2005 2010 2015 Cosmeceutical Product Demand 1870 3340 5350 8050 11850 $ chemicals/000$ products 141 146 148 150 151 Cosmeceutical Chemical Demand 263 487 790 1205 1785 Antioxidants 94 173 270 392 563 Sunscreens 46 70 110 155 210 Acids 25 59 99 160 250 Enzymes 17 36 86 160 245 Proteins 22 37 51 68 94 Botanicals 12 23 40 65 105 Other 47 89 134 205 318 Sample Profile, Table Forecast “Demand for enzymes in cosmeceuti- cal applications is expected to rise over 13 percent annually to $160 million in 2010, based on stellar growth for botuli- num toxin Type A, the key ingredient of Allergan’s popular BOTOX cosmeceutical. The prospect of other botulinum toxin- based products entering the market, as well as expanded cosmetic applications, will further stimulate gains. Other types of enzymes will also benefit, for these chemicals are increasingly being added to anti-aging skin care products due to their ability to stimulate skin cell regen- eration without the side effects generally associated with alpha hydroxy products. Enzymes will also benefit from ...” --Section IV, pg. 125 sample profile sample table Copyright 2006 The Freedonia Group, Inc.
  7. 7. The Freedonia Group, Inc. 767 Beta Drive • Cleveland, OH • 44143-2326 • USA • Web site: www.freedoniagroup.com Tel US: 800.927.5900 or +1 440.684.9600 • Fax: +1 440.646.0484 • e-mail: info@freedoniagroup.com Order Information Five Convenient Ways to Order Email Title Fax Company Division Street City/State/Zip Country Phone Name (No PO Box please) Signature Order Form Cosmeceuticals................................................................ $4400 Additional Print Copies @ $500 each * Total (including selected option) $ Enclosed is my check (5% discount) drawn on a US bank and payable to The Freedonia Group, Inc., in US funds (Ohio residents add 7.75% sales tax) Corporate Use License (add to study price) * +$2300 F-WEB.2114 Signature Signature Page 7 Corporate Use License Now every decision maker in your organization can act on the key intelligence found in all Freedonia studies. For an additional $2300, companies receive unlimited use of an electronic version (PDF) of the study. Place it on your intranet, e-mail it to coworkers around the world, or print it as many times as you like, Click here to learn more about the Corporate Use License Corporate Use License Agreement The above captioned study may be stored on the company’s intranet or shared directory, available to company employees. Copies of the study may be made, but the undersigned represents that distribution of the study will be limited to employees of the company. * Please check appropriate option and sign below to order an electronic version of the study. Individual Use License Agreement The undersigned hereby represents that the above captioned study will be used by only ___ individual(s) who are employees of the company and that the study will not be loaded on a network for multiple users. In the event that usage of the study changes, the Company will promptly notify Freedo- nia of such change and will pay to Freedonia the appropriate fee based on Freedonia’s standard fee schedule then in effect. Note: Entire company cor- porate use license, add $2300; one additional user, add $500; two additional users, add $1000; three additional users, add $1500. Bill my company VisaMasterCardAmerican Express Orders Outside of the US Checks must be made payable in US funds, drawn against a US bank and mailed directly to The Freedonia Group. For wire transfers please contact our customer service department at info@ freedoniagroup.com. Credit cards accepted. ONLINE: www.freedoniagroup.com MAIL: Print out and complete the order form and send to The Freedonia Group (see address at the bottom of this form) PHONE: Call toll free, 800.927.5900 (US) or +1 440.684.9600 FAX: +1 440.646.0484 (US) EMAIL: info@freedoniagroup.com Free Handling Shipping There is NO charge for handling or UPS shipping in the US. Expect delivery in 3 to 5 business days. Outside the US, Freedonia provides free airmail service. Express delivery is available at cost. Save 15% If you order three (3) different titles at the same time, you can receive a 15% discount. If your order is accompanied by a check or wire transfer, you may take a 5% cash discount (discounts do not apply to Corporate Use Licenses). Credit Card Orders For convenience, Freedonia accepts American Ex- press, MasterCard or Visa. Credit card purchases must include account number, expiration date and authorized signature. MM YY Credit Card # Expiration INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS
  8. 8. About The Freedonia Group The Freedonia Group, Inc., is a leading international industry market research com- pany that provides its clients with information and analysis needed to make informed strategic decisions for their businesses. Studies help clients identify business oppor- tunities, develop strategies, make investment decisions and evaluate opportunities and threats. Freedonia research is designed to deliver unibiased views and reliable outlooks to assist clients in making the right decisions. Freedonia capitalizes on the resources of its proprietary in-house research team of experienced economists, professional analysts, industry researchers and editorial groups. Freedonia covers a diverse group of industries throughout the United States, the emerging China mar- ket, and other world markets. Industries analyzed by Freedonia include: • Chemicals • Plastics • Life Sciences • Packaging • Building Materials • Security Electronics • Industrial Components Equipment • Automotive Transportation Equipment • Household Goods • Energy/Power Equipment The Freedonia Group, Inc. 767 Beta Drive • Cleveland, OH • 44143-2326 • USA • Web site: www.freedoniagroup.com Tel US: 800.927.5900 or +1 440.684.9600 • Fax: +1 440.646.0484 • e-mail: info@freedoniagroup.com Freedonia Custom Research Freedonia Custom Research delivers the same high quality, thorough and unbiased assessment of an industry or market as an industry study. Since the research initia- tive is based upon a company’s specific needs, companies harness Freedonia’s research capabilities and resources to answer unique questions. When you leverage the results of a Freedonia Custom Research engagement, you are able to obtain important answers to specific questions and issues associated with: mergers and acquisitions, new product launches/development, geographic expansion, entry into new markets, strategic business planning, and investment and funding decisions. Freedonia Custom Research is ideal for companies seeking to make a strategic dif- ference in the status quo and focus on future business growth. Working side by side with clients, Freedonia’s team is able to define a research project that is custom-tai- lored to answer specific questions and provide the basis from which a company can make informed business decisions. Click here to learn more about Freedonia Click here to learn more about Custom Research Click here to visit freedoniagroup.com Page 8 Click here for complete title list Other Studies INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS Medical Dental Adhesives Sealants US demand for medical and dental adhesives and sealants will rise 7.6% annually through 2011, driven by continuing new product development and increasing acceptance in surgical and consumer set- tings. Opportunities are expected for cyanoacrylate, polyethylene glycol and various plasma and protein types. This study analyzes the US market for medi- cal adhesives and sealants, with forecasts for 2011 and 2016 presented by product and market. It also evaluates company market share and profiles major suppliers. #2201....................05/2007..................... $4400 Dental Equipment US demand for dental equipment will grow 3.8% annually through 2011, aided by favorable population trends and strong interest in technology updates. In general, advanced equipment such as lasers, intra-oral cameras, digital radiography and CAD/CAM systems will lead gains. Dental offices will remain the largest market and grow the fastest. This study ana- lyzes the $2.4 billion US dental equipment industry to 2011 and 2016 by product and market. It also evalu- ates market share and profiles major players. #2179....................04/2007..................... $4400 Implantable Medical Devices US medical implant demand will rise 9.3% yearly through 2011. Cardiac implants will remain the top- selling group, led by stents and defibrillators. Bone cement, tissue and spinal implants will pace gains in the orthopedic segment. Other fast-growing types in- clude neurological stimulators, cochlear devices and gastric bands. This study analyzes the $27.9 billion US medical implant industry, with forecasts for 2011 and 2016 by material and product. It also evaluates market share and profiles major players. #2255....................10/2007..................... $4500 Biocompatible Materials US demand for biocompatible materials will grow 6.6% yearly through 2010. Synthetic polymers will remain dominant based on quality, performance and cost advantages in most applications. Ceramics will grow the fastest, driven by improved properties and processing ease. Hyaluronic acid and collagen will pace the natural polymer segment. This study analyzes the $2.7 billion US biocompatible industry to 2010 and 2015 by material and application. It also evaluates market share and profiles major players. #2111....................09/2006..................... $4400 Cosmetic Surgery Products US demand for cosmetic surgery products will grow 9.1% annually through 2010, driven by an obses- sion with youth coupled with an aging population and greater product availability. Nonsurgical markets (e.g., injections, dermal resurfacing, micro-dermabra- sion) will lead gains based on consumer preferences for less invasive treatments. This study analyzes the $1.6 billion US cosmetic surgery product industry to 2010 and 2015 by material, product and procedure. It also evaluates market share and profiles major players. #2099....................09/2006..................... $4300

×